Zhejiang Huahai Pharmaceutical Co Ltd (600521)

Shanghai
Currency in CNY
21.15
-1.05(-4.73%)
Closed·
600521 Scorecard
Full Analysis
Has a perfect Piotroski Score of 9
600521 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.9822.20
52 wk Range
13.4923.83
Key Statistics
Edit
Bid/Ask
21.13 / 21.15
Prev. Close
22.2
Open
21.7
Day's Range
20.98-22.2
52 wk Range
13.49-23.83
Volume
60.76M
Average Volume (3m)
39.16M
1-Year Change
23.68%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600521 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.50
Downside
-12.53%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Zhejiang Huahai Pharmaceutical Co Ltd Company Profile

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. The company was founded in 1989 and is headquartered in Linhai, China.

Employees
9065
Market
China

Compare 600521 to Peers and Sector

Metrics to compare
600521
Peers
Sector
Relationship
P/E Ratio
28.7x26.8x−0.5x
PEG Ratio
1.220.030.00
Price/Book
3.4x2.2x2.6x
Price / LTM Sales
3.5x2.8x3.1x
Upside (Analyst Target)
−12.2%9.4%47.8%
Fair Value Upside
Unlock17.2%6.9%Unlock

Analyst Ratings

2 Buy
0 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 18.50
(-12.53% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.79%
Dividend Yield
1.18%
Industry Median 1.58%
Annualised payout
0.25
Paid annually
5-Years Growth
+6.58%
Growth Streak

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
0.20 / 0.245
Revenue / Forecast
2.37B / 2.51B
EPS Revisions
Last 90 days

600521 Income Statement

FAQ

What Stock Exchange Does Zhejiang Huahai Pharm Trade On?

Zhejiang Huahai Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Zhejiang Huahai Pharm?

The stock symbol for Zhejiang Huahai Pharm is "600521."

What Is the Zhejiang Huahai Pharm Market Cap?

As of today, Zhejiang Huahai Pharm market cap is 31.29B.

What Is Zhejiang Huahai Pharm's Earnings Per Share (TTM)?

The Zhejiang Huahai Pharm EPS (TTM) is 0.79.

When Is the Next Zhejiang Huahai Pharm Earnings Date?

Zhejiang Huahai Pharm will release its next earnings report on 29 Aug 2025.

From a Technical Analysis Perspective, Is 600521 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Zhejiang Huahai Pharm Stock Split?

Zhejiang Huahai Pharm has split 10 times.

How Many Employees Does Zhejiang Huahai Pharm Have?

Zhejiang Huahai Pharm has 9065 employees.

What is the current trading status of Zhejiang Huahai Pharm (600521)?

As of 09 Jul 2025, Zhejiang Huahai Pharm (600521) is trading at a price of 21.15, with a previous close of 22.20. The stock has fluctuated within a day range of 20.98 to 22.20, while its 52-week range spans from 13.49 to 23.83.

What Is Zhejiang Huahai Pharm (600521) Price Target According to Analysts?

The average 12-month price target for Zhejiang Huahai Pharm is CNY18.5, with a high estimate of CNY23 and a low estimate of CNY13. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -12.53% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.